Ummm, nothing from Time but

New Post Public Reply Private Reply Replies (0) Message Board
Bhawks cashclan #20798
Ummm, nothing from Time but this:

Quote:
time.com/4509038/donald-trump-hillary-clinton-debate-voter-focus-group/

This Group of Undecided Voters Watched the Debate. They Think Hillary Clinton Won.

But once the debate started, Trump did not deliver.

Each voter had a dial in their hand that they could turn to register favorable or unfavorable opinions in real time. They were grouped into three trend lines: those that lean towards Trump, truly undecided, and those who lean towards Clinton.

This data showed all three categories ranking Trump extremely low when he got caught on the defensive. When moderator Lester Holt asked Trump why he hasn’t released his tax returns, even the voters leaning towards Trump rated Trump’s response in the 30s (50 is neutral). That same group went up to 70 during Clinton’s response, when she said, “There must be something that he’s hiding.”

When Trump was caught struggling to defend his previous positions on the Iraq War, claiming that he never supported it, Trump leaners and undecided dipped into the 30s, and Clinton leaners went into the 20s.

And Trump went even lower when he defended his temperament, saying it is his “strongest asset” and better than Clinton’s. At that point, Trump leaners sank to the high 20s, undecided to low 20s, and Clinton leaners to the high teens.

By comparison, when Clinton was on her back foot talking about her email scandal, undecided voters dropped to the mid-30s and Trump leaners to the 40s.

“She at least went ahead and takes responsibility for doing something wrong, while he just continues to deny any wrongdoing,” one viewer said after the debate of why he felt Clinton’s response to the email scandal was less bad than Trump’s tax return exchange.

Clinton struggled at points too; the voters judged her harshly when she attempted to attack Trump. When she quipped that Trump “just joined the debate by saying more crazy things,” the undecided line fell to 30. Whereas when Trump tried a similar personal attack against Clinton later in the debate, saying, “When you try to act holier than thou, it really doesn’t work,” the undecided line was up in the 60s.

Clinton’s best moments came discussing criminal justice reform. When Trump called for “law and order,” the voters remained about neutral. But when Clinton responded and said, “We can’t just say law and order, we have to come up with a plan,” numbers soared as she outlined her specific policy proposals. Undecided went up into the 70s, Trump leaners went up to the 60s, and Clinton leaners were all the way up in the 90s at her highest score of the night.

On the other hand, the voters responded positively when Trump called attention to problems in the nation and the issues with entrenched career politicians. When he said that President Obama and Clinton’s policies led to the rise of ISIS, undecided voters shot up to the 70s. When he talked about bringing his business sense to running the country, the lines also went up.

What never worked? When the candidates talked over each other or over the moderator. Voters almost always reacted negatively to interruptions and personal barbs between Trump and Clinton or in the instances when Trump talked over Holt.

These results show both sides of what the undecided voters want. They liked to see Trump exposing problems in the system, but they appreciated Clinton’s focus on detailed solutions. And they eschew extreme partisanship and bickering.

“I like competency and a track record of success,” one voter said after the debate. “And you didn’t get it?” Luntz asked. The voter sighed in exasperation: “Not in one person.”

After the debate, 16 viewers voted that Clinton had won, including the man who had the beginning of the night had identified himself as the most pro-Trump in the room. (“He definitely didn’t help himself,” he said of Trump afterwards.) Only six people said Trump had won.

Many were frustrated at Trump’s long-winded answers, which to them seemed to be full of sound and fury but signifying nothing, to borrow a phrase. “He dug his own grave by just talking, and talking, and talking,” one viewer said.

“If he was a student in my middle school classroom, I would have told him to finish answering the question you were being asked, and then shut your mouth,” a woman said.

In the end, the voters felt it was Trump’s failure more than Clinton’s success that swayed them tonight. But they still aren’t satisfied: “The problem is Hillary Clinton was much better prepared … But I didn’t necessarily like the answers that she gave,” one man said.

Almost all of them said they would be watching the next two debates.


you read what Fox news relied on and the other two are GOPER shiils.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Health Hit by FTC Claims and Class Action

Updated Category News Views 1

Hims Faces Harsh Lessons With FTC Lawsuit There's trouble brewing in the world of telehealth, and Hims & Hers Health (NYSE: HIMS) is right at the eye of the storm. They've gone from a darling of digital health to a pariah faster than you can say 'data breach.' On July 29, 2026, they took a hit so hard you’d think the company stepped into the ring with a heavyweight...

Continue Reading
U.S. Court Ruling Opens Market for Cocrystal's CrysQnol™

Updated Category News Views 1

Legal Drama Clears Market Path Well, folks, here’s a win from the trenches for Cocrystal Tech that can shake up the nutraceutical market. Kaneka's grip on the patent for their ubiquinol concoctions just got busted by the U.S. District Court. They ruled that Kaneka's claims lacked utility and enablement, essentially saying they were pitching an untested hypothesis as an...

Continue Reading
Regeneron Faces Class Action Over Tumultuous Trial Results

Updated Category News Views 1

Regeneron's Meltdown: A Bitter Pill for Investors Let’s dive headlong into the mess Regeneron Pharmaceuticals (NASDAQ:REGN) finds itself in—a classic nightmare scenario for investors. News broke like an old valve bursting, and suddenly, the market's love for Regeneron ran ice-cold. Who's to blame this time? Well, you might want to point a finger at the failed Phase 3...

Continue Reading
Insurance 101: Know Your Limits and Deductibles

Updated Category News Views 4

It might not exactly be cocktail party fodder, but boy, skipping on understanding your homeowners insurance is a shortcut straight to financial hell. You’re living in St. Albans, WV, in a home that’s probably your biggest investment. Let’s talk about this before you find yourself in a mess you should've seen coming. Why Coverage Limits Matter a Whole Lot Listen up,...

Continue Reading
vivo and UNESCO Unite Youth for Nature Stories

Updated Category News Views 4

Young Creators Explore Nature Through a New Lens Pontremoli, Italy just became the backdrop for an extraordinary gathering of young visionaries. From August 31 to September 5, UNESCO’s Man and the Biosphere (MAB) Programme and vivo wrapped their 2026 Capture the Future initiative in the lush landscapes of the Appennino Tosco Emiliano Biosphere Reserve. It’s one thing...

Continue Reading
Fosun Pharma Hits the Buyback Button: What's Next?

Updated Category News Views 4

Fosun Pharma's Bold Move Well, if this isn't Fosun Pharma making some noise! Announcing an H-share repurchase plan worth up to HK$1 billion is like setting off fireworks amidst any investor's evening. They're hollering to the market, 'We see value, and we're doubling down on it.' Crunching the Numbers In the first half of 2026, Fosun Pharma's numbers weren't just a flash...

Continue Reading
Nurminen Logistics Doubles Sweden–Italy Rail Capacity

Updated Category News Views 4

Nurminen Logistics Betting Big on Rail Expansion Feeling the pulse of the logistics world is much like trying to catch lightning in a bottle, but Nurminen Logistics seems to have found its rhythm. They're ramping up their services between Sweden and Italy, leveraging rail to push the envelope. Come October, they're doubling down from one to two weekly departures, giving...

Continue Reading
ACG Moves to Acquire Ke?kek for $7.85M Gold Venture

Updated Category News Views 3

Here's the scoop: ACG Metals Limited is stepping up the game, attempting to snag the Ke?kek gold project in a deal worth up to $7.85 million. This move, they say, is all about bolstering the future of their gold production—and squeezing every ounce out of that Gediktepe facility in Türkiye. It's like squeezing juice from a lemon that's still got a bit of life left....

Continue Reading
Aroa Biosurgery Reports Low Infection Rates: A Milestone

Updated Category News Views 3

Peer-Reviewed Study: Aroa's Myriad Shows Low Infection Rates Seems like the folks at Aroa Biosurgery have got something solid to brag about in the world of complex soft tissue reconstruction. The company just released interim results from their massive MASTRR Registry study, and the numbers are looking pretty darn promising. We're talking about a 411-patient analysis...

Continue Reading
Consumer365 Highlights Happy Head's Personalized Hair Solutions

Updated Category News Views 1

Tailored Hair Loss Solutions by Happy Head Imagine trying to fit a square peg in a round hole. That's what one-size-fits-all approaches often feel like in the world of hair loss treatments. Happy Head, recognized by Consumer365, takes that notion and turns it on its head, offering personalized minoxidil formulations for women. The key word here is personalized. More Than...

Continue Reading

Top 5 Most Recently Viewed Articles

Avocados From Mexico Celebrates Certification as Great Employer

Updated Category News Views 51

Avocados From Mexico Achieves Prestigious Great Place To Work Certification Avocados From Mexico is widely recognized not just as the top-selling avocado brand in the United States, but also as a Certified Great Place To Work. This esteemed certification reflects the positive feedback from current employees regarding their experiences within the company. An impressive 97%...

Continue Reading
Etex Shows Stability and Growth Amid Market Challenges in 2025

Updated Category News Views 370

Etex's Strong Half-Year Financial Performance Etex has demonstrated significant resilience in its half-year financial performance, navigating a construction environment that remains largely unpredictable. This strength is highlighted by a steady sales volume and healthy margins, confirming the company's expectations for the period. Overview of Financial Results The...

Continue Reading
First Horizon Bank Becomes Official Partner of NC Courage

Updated Category News Views 111

First Horizon Bank Officially Partners with NC Courage In an exciting development for women's sports, First Horizon Bank (NYSE: FHN) has been named the Official Bank of the North Carolina Courage, marking the start of a multiyear partnership aimed at bolstering community initiatives. This collaboration is an incredible opportunity to enhance support for women's athletics...

Continue Reading
Curis Announces Upcoming Presentations on Emavusertib Research

Updated Category News Views 193

Curis Prepares for Major Presentations at SNO Meeting LEXINGTON, Mass. — Curis, Inc. (NASDAQ: CRIS) is excited to share that the company will participate in the prestigious 30th Annual Meeting of the Society for Neuro-Oncology (SNO). This event is taking place soon, and Curis intends to showcase significant clinical data regarding emavusertib (CA-4948), a promising...

Continue Reading
Novel Approach to PTSD Treatment Unveiled in Recent Study

Updated Category News Views 391

Recent Advancements in PTSD Research Otsuka Pharmaceutical Development & Commercialization, Inc. and Lundbeck LLC have made headlines with the publication of a Phase 3 trial of brexpiprazole combined with sertraline for treating Post-Traumatic Stress Disorder (PTSD) in adults. The findings, appearing in JAMA Psychiatry, indicate a significant improvement in PTSD symptoms...

Continue Reading